Indications and uses
Relieves: Heartburn Sour stomach Acid indigestion Upset stomach associated with these symptoms
Relieves: Heartburn Sour stomach Acid indigestion Upset stomach associated with these symptoms
Use enclosed spoon. Take one spoonful in the morning with a glass of water. If needed, take a second spoonful in the evening, or as directed by a doctor. Do not take more than 2 spoonfuls in a 24-hour period. If you are over 60 years old, do not take more than 1 spoonful. Not for children under 12 years. Do not take maximum dose for more than 2 weeks.
Do not use after expiration date. Store at room temperature. Protect from heat and light. Sodium per spoonful 1500 mg. Potassium per spoonful 190 mg.
5.3 oz
(150 g)
Drug Facts
| Active Ingredients | Purposes |
|---|---|
| Potassium bicarbonate (7.8%) | Antacid |
| Sodium bicarbonate (78%) | Antacid |
| Sodium citrate (1.6%) | Antacid |
Relieves:
Keep out of reach of children.
This container has been designed for your safety to ensure product freshness. Do not use after expiration date. Do not use if the seal between the cap and container is broken or missing or imprinted security strip on carton is torn.
calcium lactate, sea salt, silica, sodium sulfate
Rev. 03/2007
Made in Germany by
Sanum-Kehlbeck GmbH
Germany
Distributed by:
SANUM USA Corp.
1465 Slater Road, Ferndale, WA 98248
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1251782 | Pleo Alkala 7.8 % / 78 % / 1.6 % Powder for Oral Solution | PSN | 1 |
| 1251780 | potassium bicarbonate 7.8 % / sodium bicarbonate 78 % / sodium citrate 1.6 % Powder for Oral Solution | PSN | 1 |
| 1251782 | potassium bicarbonate 11700 MG / sodium bicarbonate 117000 MG / sodium citrate 2400 MG Powder for Oral Solution [Pleo Alkala] | SBD | 1 |
| 1251780 | potassium bicarbonate 11700 MG / sodium bicarbonate 117000 MG / sodium citrate 2400 MG Powder for Oral Solution | SCD | 1 |
| 1251780 | K+ bicarbonate 11700 MG / NaHCO3 117000 MG / sodium citrate 2400 MG Powder for Oral Solution | SY | 1 |
| 1251782 | K+ bicarbonate 11700 MG / NaHCO3 117000 MG / sodium citrate 2400 MG Powder for Oral Solution [Pleo Alkala] | SY | 1 |
| 1251782 | Pleo Alkala 7.8 % / 78 % / 1.6 % Powder for Oral Solution | SY | 1 |
| 1251780 | Pot bicarbonate 11700 MG / NaHCO3 117000 MG / sodium citrate 2400 MG Powder for Oral Solution | SY | 1 |
| 1251782 | Pot bicarbonate 11700 MG / NaHCO3 117000 MG / sodium citrate 2400 MG Powder for Oral Solution [Pleo Alkala] | SY | 1 |
| 1251780 | potassium bicarbonate 7.8 % / sodium bicarbonate 78 % / sodium citrate 1.6 % Powder for Oral Solution | SY | 1 |
| Class | Version | Type | Effective |
|---|---|---|---|
| POTASSIUM CATION Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| SODIUM CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 60681-6001-1 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-dcf2-621f-e053-dbdaa90a74ad | "The Original" Pleo™ Alkala Antacid Powder |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60681-6001-1 | Pleo Alkala Antacid | 1 in 1 CARTON | POWDER | 1 | 1 | |
| 60681-6001-1 | Pleo Alkala Antacid | 150 g in 1 BOTTLE, PLASTIC | POWDER | 150 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60681-6001 | PLEO ALKALA ANTACID (SODIUM BICARBONATE, POTASSIUM BICARBONATE AND SODIUM CITRATE) POWDER [SANUM KEHLBECK GMBH & CO. KG] | 1 | Legacy NDC, 2 package rows | 20091023_7dca3271-4810-45d0-8b02-0bb0941bcc6f.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| potassium bicarbonate | ACTIVE INGREDIENT | HM5Z15LEBN | 1 | |
| sodium bicarbonate | ACTIVE INGREDIENT | 8MDF5V39QO | 1 | |
| sodium citrate | ACTIVE INGREDIENT | 1Q73Q2JULR | 1 | |
| potassium cation | ACTIVE MOIETY | 295O53K152 | 1 | |
| sodium cation | ACTIVE MOIETY | LYR4M0NH37 | 1 | |
| calcium lactate | INACTIVE INGREDIENT | 2URQ2N32W3 | 1 | |
| sea salt | INACTIVE INGREDIENT | 87GE52P74G | 1 | |
| sodium sulfate | INACTIVE INGREDIENT | 0YPR65R21J | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 60681-6001 | 60681-6001-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| sodium bicarbonate | 8MDF5V39QO | ACTIB |
| potassium bicarbonate | HM5Z15LEBN | ACTIB |
| sodium citrate | 1Q73Q2JULR | ACTIB |
| calcium lactate | 2URQ2N32W3 | IACT |
| sea salt | 87GE52P74G | IACT |
| sodium sulfate | 0YPR65R21J | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| sodium sulfate | SODIUM SULFATE | 0YPR65R21J | SHAMPOO / TOPICAL | 5 %w/w | ||
| sodium sulfate | SODIUM SULFATE | 0YPR65R21J | SOAP / TOPICAL | 0.05 %w/w | ||
| sodium sulfate | SODIUM SULFATE | 0YPR65R21J | TABLET / ORAL | 182 mg | ||
| sodium sulfate | SODIUM SULFATE | 0YPR65R21J | TABLET, COATED / ORAL | NA | ||
| sodium sulfate | SODIUM SULFATE | 0YPR65R21J | SOLUTION/ DROPS / OPHTHALMIC | 13 mg | ||
| sodium sulfate | SODIUM SULFATE | 0YPR65R21J | TABLET, DELAYED RELEASE / ORAL | 16.24 mg | ||
| sodium sulfate | SODIUM SULFATE | 0YPR65R21J | SOLUTION / OPHTHALMIC | 0.14 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 10098eed-072a-409e-8873-02a570e3c285 | 7dca3271-4810-45d0-8b02-0bb0941bcc6f | 2009-10-16 | Warnings | 10098eed-072a-409e-8873-02a570e3c285 7dca3271-4810-45d0-8b02-0bb0941bcc6f |
Adverse event summaries are temporarily unavailable. Other product information remains available.